Molecular Cancer Research

Journal

Publication Venue For

  • Suppression of SIN3A by miR-183 Promotes Breast Cancer Metastasis.  20:883-894. 2022
  • Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.  20:150-160. 2022
  • Fibrinogen alpha chain knockout promotes tumor growth and metastasis through integrin-akt signaling pathway in lung cancer.  18:943-954. 2020
  • Mesenchymal and MAPK expression signatures associate with telomerase promoter mutations in multiple cancers.  18:1052-1062. 2020
  • An emerging regulatory role for the tumor microenvironment in the DNA damage response to double-strand breaks.  18:185-193. 2020
  • The germline variants rs61757955 and rs34988193 are predictive of survival in lower grade glioma patients.  17:1075-1086. 2019
  • Molecular correlates of metastasis by systematic pan-cancer analysis across the cancer genome atlas.  17:476-487. 2019
  • Integrative epigenetic and gene expression analysis of renal tumor progression to metastasis.  17:84-96. 2019
  • LINC00152 promotes invasion through a 30'-hairpin structure and associates with prognosis in glioblastoma.  16:1470-1482. 2018
  • Runx2 suppression by miR-342 and miR-363 inhibits multiple myeloma progression.  16:1138-1148. 2018
  • miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression.  16:1125-1137. 2018
  • Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma.  16:813-824. 2018
  • Multigene profiling of CTCs in mCRPC identifies a clinically relevant prognostic signature.  16:643-654. 2018
  • Sympathetic signaling reactivates quiescent disseminated prostate cancer cells in the bone marrow.  15:1644-1655. 2017
  • Normal and cancerous tissues release extrachromosomal circular DNA (eccDNA) into the circulation.  15:1197-1205. 2017
  • Epigenetic regulation of ZBTB18 promotes glioblastoma progression.  15:998-1011. 2017
  • Mutant IDH1 disrupts the mouse subventricular zone and alters brain tumor progression.  15:507-520. 2017
  • Let-7 status is crucial for PARP1 expression in HER2-overexpressing breast tumors.  15:340-347. 2017
  • Notch signaling activation is associated with patient mortality and increased FGF1-mediated invasion in squamous cell carcinoma of the oral cavity.  14:883-891. 2016
  • STAT1 and NF-κB inhibitors diminish basal interferon-stimulated gene expression and improve the productive infection of oncolytic HSV in MPNST Cells.  14:482-492. 2016
  • Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett's-associated Esophageal Adenocarcinoma. 2016
  • The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive nexus.  13:828-838. 2015
  • Variants of osteoprotegerin lacking trail binding for therapeutic bone remodeling in osteolytic malignancies.  13:819-827. 2015
  • Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow.  13:197-207. 2015
  • A functional screen identifies miRs that induce radioresistance in glioblastomas.  12:1767-1778. 2014
  • The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer. 2014
  • Base excision repair defects invoke hypersensitivity to PARP inhibition.  12:1128-1139. 2014
  • FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.  12:514-526. 2014
  • BRSM1 promoter methylation provides prognostic information in primary breast tumors.  11:1248-1257. 2013
  • Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.  11:494-505. 2013
  • Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma.  11:349-359. 2013
  • Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.  10:703-712. 2012
  • Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype.  10:282-292. 2012
  • Hedgehog signaling: Networking to nurture a promalignant tumor microenvironment.  9:1165-1174. 2011
  • Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.  9:1008-1017. 2011
  • The RNA-binding protein HuR promotes glioma growth and treatment resistance.  9:648-659. 2011
  • Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells.  9:403-417. 2011
  • αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.  9:1632-1643. 2011
  • Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.  8:1425-1436. 2010
  • Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells.  8:775-782. 2010
  • Expression of PGK1 by prostate cancer cells induces bone formation.  7:1595-1604. 2009
  • Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers.  6:1710-1717. 2008
  • Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.  6:1534-1543. 2008
  • Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas.  6:675-684. 2008
  • CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.  6:546-554. 2008
  • Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.  4:437-447. 2006
  • Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro.  3:195-202. 2005
  • Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.  11:425-435. 2000
  • The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin.  10:503-516. 1999
  • Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: Transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF.  10:423-434. 1999
  • Concordant induction of cyclin E and p21(cip1) in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and vital DNA synthesis.  10:101-111. 1999
  • Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) β1 in cells with nonfunctional TGF-β receptor type III.  10:11-18. 1999
  • Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.  9:229-238. 1998
  • Induction of the nuclear orphan receptor RORγ during adipocyte differentiation of D1 and 3T3-L1 cells.  9:267-276. 1998
  • Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.  9:313-325. 1998
  • Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.  8:751-762. 1997
  • Tissue-specific expression of human acahaete-scute homologue-1 in neuroendocrine tumors: Transcriptional regulation by dual inhibitory regions.  8:677-686. 1997
  • Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus.  8:425-434. 1997
  • Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice.  8:121-131. 1997
  • Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.  7:1345-1351. 1996
  • Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: Effects of retinoid-receptor selective ligands.  7:327-337. 1996
  • γ-Interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma.  7:289-300. 1996
  • p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.  7:197-202. 1996
  • Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor α gene in an epidermal growth factor-dependent manner.  5:87-93. 1994
  • Transforming growth factor β1 suppresses transformation in hepatocytes by regulating α1β1 integrin expression.  5:509-517. 1994
  • Multiple signal transduction pathways mediate c-Jun protein phosphorylation..  4:377-385. 1993
  • Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures..  3:471-483. 1992
  • Expression of a preprorelaxin-like gene during squamous differentiation of rabbit tracheobronchial epithelial cells and its suppression by retinoic acid..  3:549-556. 1992
  • Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes..  3:577-588. 1992
  • Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes..  3:693-704. 1992
  • Expression of nuclear retinoic acid receptors in wild-type and mutant embryonal carcinoma PCC4.aza1R cells..  1:535-542. 1990
  • International Standard Serial Number (issn)

  • 1044-9523
  • 1541-7786
  • Electronic International Standard Serial Number (eissn)

  • 1557-3125